Tirzepatide Dosage & Reconstitution in 2026: How to Use It

Tirzepatide is a once-weekly injection that starts low and steps up slowly, a process called titration. A common schedule begins at 2.5 mg per week and increases every four weeks through 5, 7.5, 10, and 12.5 mg, up to a maximum of 15 mg.

The slow ramp gives your body time to adjust and helps limit stomach side effects. This page explains the common titration chart, how compounded tirzepatide is reconstituted, how to read your dose on an insulin syringe, and how pru handles the whole process. Your prescriber sets your actual doses, and your pharmacy label always wins.

The tirzepatide titration schedule (2.5 to 15 mg)

Tirzepatide is increased gradually, one step at a time, so your body can adjust. The common schedule starts at 2.5 mg once a week and steps up by 2.5 mg every four weeks, up to a ceiling of 15 mg per week. The 2.5 mg dose is a starting dose, not a target.

The 7.5 mg and 12.5 mg steps are usually bridges between the common maintenance doses of 5, 10, and 15 mg. You do not have to reach the top. Many people settle at a lower dose that works for them, and your prescriber decides when and whether to move up.

How compounded tirzepatide is reconstituted

Compounded tirzepatide often ships as a freeze-dried powder in a vial that you mix, or reconstitute, before the first dose. You add bacteriostatic water, which contains 0.9% benzyl alcohol to keep the vial usable across several doses. Your pharmacy provides the exact amount of water to add and the concentration for your vial. Do not guess. The label and instructions that come with your kit are what you follow.

1. Wash your hands and set out your vial, the bacteriostatic water, an alcohol swab, and a mixing syringe.
2. Wipe both vial tops with the alcohol swab and let them dry.
3. Draw up the exact amount of bacteriostatic water your pharmacy specifies.
4. Inject the water slowly down the inside wall of the tirzepatide vial. Do not spray it onto the powder.
5. Swirl gently until the powder fully dissolves. Do not shake it hard.
6. Let it sit until the liquid is clear, then store it in the refrigerator.

How to measure a tirzepatide dose on a U-100 insulin syringe

Tirzepatide doses are drawn on a U-100 insulin syringe, and your dose is measured in units on the syringe, not milligrams. The number of units depends on the concentration your pharmacy mixed. A common example is a 10 mg/mL concentration, where each 10 units on a U-100 syringe equals 1 mg. Your kit tells you the exact unit mark for your dose. When it does, that mark is what you use.

If your pharmacy mixes a different concentration, these unit numbers change. That is exactly why you never copy a chart from the internet for your own vial. Read your label, match the unit mark, and ask your pharmacy if anything is unclear.

Dose-related side effects of tirzepatide

Most tirzepatide side effects are stomach related and tend to show up when you start or step up your dose. The most common are nausea, diarrhea, vomiting, constipation, decreased appetite, and abdominal discomfort. In clinical trials of the branded products, nausea and diarrhea were among the most reported effects, and they were more likely at higher doses. The slow titration schedule exists to blunt these effects while your body adapts, and for many people they ease over time.

• Nausea, the most commonly reported effect, often strongest right after a step up
• Diarrhea or constipation
• Vomiting and reduced appetite
• Upper abdominal discomfort or pain
• Injection-site reactions
• Semaglutide dosage and titration
• Compounded tirzepatide, explained
• Tirzepatide vs Mounjaro and Zepbound
• Where to buy compounded tirzepatide
• see it on pru

The real tirzepatide risk is grey-market vials, not the medicine

The biggest risk with tirzepatide is not the medicine itself, it is where it comes from. Online you will find vials labeled "research grade" or "not for human use," sold with no prescription and no oversight. Those are not pharmacy medicine. No licensed prescriber reviewed your health, and no regulated pharmacy verified what is actually in the vial. Purity, dosing, and sterility are unknown.

Pharmacy-grade compounded tirzepatide is different. A licensed physician reviews your health and writes a prescription, and a state-licensed 503A pharmacy compounds it for you by name. That oversight is the whole point, and it is the line pru refuses to cross.

Who should not take tirzepatide

Tirzepatide is not right for everyone, and that is exactly what the screening step is for. You should not take tirzepatide if you or a family member has had medullary thyroid carcinoma (MTC), a type of thyroid cancer, or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), a genetic condition that raises that cancer risk.

Tirzepatide is also not used during pregnancy or when you are planning to become pregnant. Because it can affect weight and metabolism, most clinicians advise stopping it well before a planned pregnancy. If you could become pregnant, talk with your prescriber about timing and birth control.

• A personal or family history of medullary thyroid carcinoma (MTC)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• Pregnancy, or a plan to become pregnant
• A prior serious allergic reaction to tirzepatide

Missed doses and storage

Tirzepatide is a once-weekly injection, so a missed dose is common and usually easy to handle. The general guidance is to take a missed dose as soon as you can if it is within about 4 days (96 hours) of when it was due.

If more than 4 days have passed, skip that dose and take your next one on your regular day. Never take two doses within 3 days of each other to make up for a missed one. Doubling up does not help and can worsen stomach side effects.

• Store tirzepatide in the refrigerator at 36 to 46 F (2 to 8 C).
• Do not freeze it, and do not use it if it has been frozen.
• Protect it from light and keep it in its original container until use.
• Never use liquid that is cloudy, discolored, or has particles in it.

Mounjaro and Zepbound: two tirzepatide brands, different uses

Mounjaro and Zepbound are both FDA-approved tirzepatide products from Eli Lilly. They differ by what they are approved to treat. Mounjaro is approved for type 2 diabetes. Zepbound is approved for weight management and for obstructive sleep apnea in adults with obesity. The two brands separate by their approved use, not by anything you do differently at home. For a full side-by-side, see our tirzepatide vs Mounjaro and Zepbound guide.

How pru handles tirzepatide dosing

Deciding to take your metabolic health seriously is a smart, proactive move, and pru exists to make that choice the accessible one. With pru, a licensed physician reviews your health, sets your tirzepatide titration, and writes the prescription.

A state-licensed 503A compounding pharmacy fills it for you as a named patient, and it arrives with clear instructions and a label that sets your exact dose. You are never mixing blind or guessing at units. GLP-1 medicines like tirzepatide are peptides, and pru is the focused, complete place for peptides.

Compounded tirzepatide is a distinct, prescribed, non-FDA-approved medication made for you individually. It is not the same as the branded FDA-approved products, Mounjaro and Zepbound, from Eli Lilly. What pru changes is access, cost, and support. Weigh your options in semaglutide vs tirzepatide.

The best part is the price. Your flat membership funds the platform, and every peptide is priced at cost, itemized so you see the pharmacy fill, supplies, shipping, and consult with no markup on the medicine. Start with tirzepatide, browse weight loss and metabolism, or see exactly how pricing works. When you are ready to take the next step, the smart path and the easy one are the same. Peptides made simple, for everyone.

Common questions